BG63083B1 - Заместени тетрациклични тетрахидрофуранови производни - Google Patents

Заместени тетрациклични тетрахидрофуранови производни Download PDF

Info

Publication number
BG63083B1
BG63083B1 BG102820A BG10282098A BG63083B1 BG 63083 B1 BG63083 B1 BG 63083B1 BG 102820 A BG102820 A BG 102820A BG 10282098 A BG10282098 A BG 10282098A BG 63083 B1 BG63083 B1 BG 63083B1
Authority
BG
Bulgaria
Prior art keywords
alkyl
formula
compounds
compound according
aryl
Prior art date
Application number
BG102820A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG102820A (en
Inventor
Pilar Gil-Lopetegui
Francisco Fernandez-Gadea
Theo Meert
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8223868&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG63083(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of BG102820A publication Critical patent/BG102820A/xx
Publication of BG63083B1 publication Critical patent/BG63083B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Addiction (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG102820A 1996-04-12 1998-10-07 Заместени тетрациклични тетрахидрофуранови производни BG63083B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96200990 1996-04-12
PCT/EP1997/001829 WO1997038991A1 (en) 1996-04-12 1997-04-09 Substituted tetracyclic tetrahydrofuran derivatives

Publications (2)

Publication Number Publication Date
BG102820A BG102820A (en) 1999-08-31
BG63083B1 true BG63083B1 (bg) 2001-03-30

Family

ID=8223868

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102820A BG63083B1 (bg) 1996-04-12 1998-10-07 Заместени тетрациклични тетрахидрофуранови производни

Country Status (30)

Country Link
US (3) US6057441A (pl)
EP (1) EP0892793B1 (pl)
JP (1) JP3199751B2 (pl)
KR (1) KR100389298B1 (pl)
CN (1) CN1116291C (pl)
AT (1) ATE236893T1 (pl)
BG (1) BG63083B1 (pl)
BR (1) BR9706639A (pl)
CA (1) CA2232141C (pl)
CY (1) CY2382B1 (pl)
CZ (1) CZ288865B6 (pl)
DE (1) DE69720709T2 (pl)
DK (1) DK0892793T3 (pl)
EA (1) EA001002B1 (pl)
EE (1) EE03612B1 (pl)
ES (1) ES2196328T3 (pl)
HK (1) HK1015771A1 (pl)
HU (1) HUP9901613A3 (pl)
IL (1) IL123655A (pl)
MY (1) MY119321A (pl)
NO (1) NO317156B1 (pl)
NZ (1) NZ329953A (pl)
PL (1) PL190960B1 (pl)
PT (1) PT892793E (pl)
SI (1) SI0892793T1 (pl)
SK (1) SK283400B6 (pl)
TR (1) TR199801164T2 (pl)
TW (1) TW504506B (pl)
WO (1) WO1997038991A1 (pl)
ZA (1) ZA973114B (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT892793E (pt) * 1996-04-12 2003-08-29 Janssen Pharmaceutica Nv Derivados 2-cianoiminoimidazolo inibidores da pde iv
UA52778C2 (uk) 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
US20050148018A1 (en) 1999-10-07 2005-07-07 David Weiner Methods of identifying inverse agonists of the serotonin 2A receptor
HRP20000310A2 (en) * 2000-05-17 2002-02-28 Pliva Farmaceutska Ind Dioniko New dibenzoazulene compounds as tumor necrosis factor inhibitors
WO2002056873A2 (en) * 2000-12-22 2002-07-25 Bayer Pharmaceuticals Corporation 2-substituted dibenzo[a,e]1,2,3-triazolo[4,5-c][7]annulen-8-ones as growth hormone secretagogues
UA79248C2 (en) * 2001-11-09 2007-06-11 Janssen Pharmaceutica Nv Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
US6998494B2 (en) * 2001-12-07 2006-02-14 Janssen Pharmaceutica N.V. Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives
CN1697833A (zh) * 2001-12-07 2005-11-16 詹森药业有限公司 顺式－稠合的3,3a,8,12b－四氢－2H－二苯并[3,4:6,7]环庚并[1,2－b]呋喃衍生物的制备方法
HRP20020305A8 (en) 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20030160A2 (en) * 2003-03-06 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. 1-thiadibenzoazulene derivatives and biological action thereof
HRP20030885A2 (en) * 2003-11-03 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS
HRP20030958A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1,3-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030957A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1-THIA-3-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030953A2 (en) * 2003-11-21 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. PREPARATION OF 1-AZA-2-OXA-DIBENZO[e,h]AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030956A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1,2-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANU
HRP20030955A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1-OXADIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030954A2 (en) * 2003-11-21 2005-08-31 Pliva D.D. USE OF 1-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20040104A2 (en) * 2004-01-30 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
US20070197525A1 (en) * 2004-06-14 2007-08-23 Cid-Nunez Jose M Novel tetracyclic tetrahydrofuran derivatives
CA2568752C (en) 2004-06-23 2013-05-07 Janssen Pharmaceutica N.V. Novel unsaturated tetracyclic tetrahydrofuran derivatives
CA2588760C (en) 2004-12-07 2014-05-13 Janssen Pharmaceutica N.V. Substituted tetracyclic tetrahydropyran, pyrrolidine and tetrahydrothiophene derivatives
AU2011202995B2 (en) * 2004-12-07 2012-02-02 Janssen Pharmaceutica N.V. Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
EA013595B1 (ru) 2005-01-27 2010-06-30 Янссен Фармацевтика Н.В. Гетероциклические, тетрациклические производные гидрофурана в качестве ингибиторов 5htв терапии расстройств цнс
JP2008540606A (ja) 2005-05-19 2008-11-20 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 環状アミン側鎖を含有する選ばれた四環式テトラヒドロフラン誘導体
NZ562008A (en) * 2005-05-26 2010-03-26 Janssen Pharmaceutica Nv Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament
ES2342110T3 (es) * 2005-06-17 2010-07-01 Janssen Pharmaceutica Nv Nuevos derivados tetraciclicos de tetrahidrofurano que contienen una cadena lateral de amina ciclica.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7605526A (nl) * 1976-05-24 1977-11-28 Akzo Nv Nieuwe tetracyclische derivaten.
DE2742794A1 (de) * 1976-11-15 1978-05-18 Dec Int Vorrichtung zur befoerderung von gemahlenem kaese
DE68924751T2 (de) * 1988-09-26 1996-04-11 Smithkline Beecham Farma Azacyclische Verbindungen, verwendbar als Arzneimittel.
MY110227A (en) * 1991-08-12 1998-03-31 Ciba Geigy Ag 1-acylpiperindine compounds.
FR2681320B1 (fr) * 1991-09-12 1994-01-14 Synthelabo Derives de n-(4,7dimethoxyindan-2-yl)-1-(phenylcarbonyl)-n-propyl-piperidine-4-methanamine, leur preparation et leur application en therapeutique.
FR2681325B1 (fr) * 1991-09-16 1993-12-17 Fabre Medicament Pierre Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
JP3064425B2 (ja) * 1995-09-15 2000-07-12 ノイロサーチ アクティーゼルスカブ カルシウムチャンネル・ブロッカーとしてのピペリジン化合物
PT892793E (pt) * 1996-04-12 2003-08-29 Janssen Pharmaceutica Nv Derivados 2-cianoiminoimidazolo inibidores da pde iv

Also Published As

Publication number Publication date
NO981076D0 (no) 1998-03-11
CA2232141C (en) 2006-05-23
EE03612B1 (et) 2002-02-15
ATE236893T1 (de) 2003-04-15
MY119321A (en) 2005-05-31
EP0892793A1 (en) 1999-01-27
SI0892793T1 (en) 2003-10-31
PL190960B1 (pl) 2006-02-28
EP0892793B1 (en) 2003-04-09
PT892793E (pt) 2003-08-29
NO981076L (no) 1998-10-09
TW504506B (en) 2002-10-01
CN1205006A (zh) 1999-01-13
IL123655A (en) 2001-03-19
HUP9901613A2 (hu) 1999-09-28
PL328575A1 (en) 1999-02-01
AU2695997A (en) 1997-11-07
DK0892793T3 (da) 2003-07-21
ZA973114B (en) 1998-10-12
AU712154B2 (en) 1999-10-28
SK283400B6 (sk) 2003-07-01
US6288058B1 (en) 2001-09-11
US6057441A (en) 2000-05-02
NZ329953A (en) 1999-06-29
CY2382B1 (en) 2004-06-04
WO1997038991A1 (en) 1997-10-23
KR100389298B1 (ko) 2003-10-30
DE69720709T2 (de) 2004-03-11
BR9706639A (pt) 1999-01-12
CZ288865B6 (cs) 2001-09-12
JP2000508327A (ja) 2000-07-04
IL123655A0 (en) 1998-10-30
CZ324398A3 (cs) 1999-01-13
EA001002B1 (ru) 2000-08-28
KR19990067514A (ko) 1999-08-25
HK1015771A1 (en) 1999-10-22
DE69720709D1 (de) 2003-05-15
SK141898A3 (en) 1999-03-12
EA199800348A1 (ru) 1998-10-29
US6194405B1 (en) 2001-02-27
CA2232141A1 (en) 1997-10-23
HUP9901613A3 (en) 2001-08-28
JP3199751B2 (ja) 2001-08-20
BG102820A (en) 1999-08-31
TR199801164T2 (xx) 1998-10-21
ES2196328T3 (es) 2003-12-16
CN1116291C (zh) 2003-07-30
EE9800326A (et) 1999-04-15
NO317156B1 (no) 2004-08-30

Similar Documents

Publication Publication Date Title
BG63083B1 (bg) Заместени тетрациклични тетрахидрофуранови производни
ES2263971T3 (es) Compuestos y su uso como inhibidores de 5-ht.
JP6174997B2 (ja) ホスホジエステラーゼ阻害剤としてのベンゾジオキソールまたはベンゾジオキセピンヘテロ環化合物
US20020107254A1 (en) Serotonergic agents
CZ296928B6 (cs) Tetracyklický derivát tetrahydrofuranu substituovaný halogenem, zpusob jeho prípravy a pouzití a prostredek s jeho obsahem
JPS61246184A (ja) ジアンヒドロヘキシツト誘導体、その製造方法およびその医薬としての用途
JPS6267031A (ja) 胃腸ぜん動の調節物質としてのα↓２−アドレナリン受容体拮抗物質
DE3851925T2 (de) Alkylaminalkoxyphenyl-Derivate, Verfahren zur Verwendung und sie enthaltende Zusammensetzungen.
TW210338B (pl)
EP2880023A1 (fr) Derives de griseofulvine
JP2001515899A (ja) テトラヒドロガンマ−カルボリン類
JPH02270819A (ja) 複素環式アミノ化合物の製法及びこの化合物を含む医薬製剤
EP0446921B1 (en) Optically active alkylene-dioxybenzene derivatives and their use in therapy
WO1997017970A1 (fr) Inhibiteurs de la neurotoxicite de l'acide kainique et derives de la pyridothiazine
WO2022229061A1 (en) Furoindazole derivatives as antagonists or inhibitors of gpr84
KR20010071844A (ko) 의약으로서의 트리사이클릭 δ3-피페리딘
JPH11501021A (ja) プロキネティック オキサジアゾール
JP2002514643A (ja) ベンゾフラン誘導体、それを含有する製薬学的な組成物及びその活性成分の製造方法。
US5234948A (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
US7816362B2 (en) Serotonergic agents
BG65162B1 (bg) Бензизоксазоли и фенони като алфа 2-антагонисти
RU2126008C1 (ru) Производные диазабициклоалкенов и фармацевтическая композиция
KR830000614B1 (ko) 이미다졸 유도체의 제조방법
JP3165409B2 (ja) アルキレンジオキシベンゼン誘導体を有効成分とする抗不安薬
JPH11310532A (ja) 熱産生促進剤